Project Grant HT94252510386
Award Date
6/15/25
Completion Date
6/14/28
Dollars Obligated
$540K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02138, USA
Similar Awards
This $1,186,517 Project Grant was awarded by the Defense Health Agency on August 1, 2023 to Harvard College President & Fellows Of Harvard T.H. Chan School Of Public Health under the Military Medical Research and Development (CFDA 12.420) program. The goal of the 3-year project is to REVEAL AND TARGET LIPIDOMIC VULNERABILITIES TO TREAT METASTATIC MELANOMA. Harvard T.H. Chan School of Public Health will conduct research to investigate new ways to treat this deadly form of skin cancer. No...
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
This federal Project Grant award, valued at $1,498,368.00 and issued by the Defense Health Agency, supports research conducted by The General Hospital Corporation (doing business as Massachusetts General Hospital) under the Military Medical Research and Development (CFDA 12.420) program. The research aims to elucidate the molecular mechanisms of tumor-immune dynamics and evolution in response to radiation, with the goal of optimizing treatment for high- and very high-risk prostate cancer. The...
This $1,014,000 project grant from the Defense Health Agency will fund research into targeted therapeutic opportunities for ovarian clear cell, small cell, and endometrioid carcinomas at President And Fellows of Harvard College from May 1, 2023 to April 30, 2027. The grant falls under the Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions. Through this...
This federal Project Grant award in the amount of $1,229,700.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is supporting research conducted by the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts focused on "DISSECTION OF MOLECULAR ASSOCIATIONS OF RESPONSE TO NEOADJUVANT ANTIANDROGEN THERAPIES IN HIGH-RISK LOCALIZED PROSTATE CANCER." The 4-year research project aims to advance the...
This federal Project Grant award, valued at $254,233, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research by Harvard Medical School to investigate the regulation of steroid hormone signaling and lipid metabolism by the tuberous sclerosis complex. The project will run from April 1, 2025 to March 31, 2027. As a sub-recipient, Harvard Medical School has a strong track record of delivering sophisticated...
This $676,147 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports a research initiative led by Harvard University to develop data-driven biomarker-informed decision analytics to improve the efficacy and reduce the toxicity of immune checkpoint blockade therapy for melanoma patients. The 3-year project aims to leverage advanced analytics and biomarker data to optimize the use of this cutting-edge cancer...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $676,000.00 to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research on developing HUWE1 as a therapeutic target for treating mesothelioma. The award period runs from July 1, 2025 to June 30, 2027. Harvard Medical School, a renowned academic and research institution, will leverage its expertise in biomedical...
This federal Project Grant award of $1,460,695.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund the "DEVELOPMENT AND VALIDATION OF AN EPIGENOMIC LANDSCAPE AND NOVEL IMMUNOTHERAPY IN PROSTATE CANCER DISPARITIES" over the period of September 1, 2025 to August 31, 2028. The award recipient is The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc., a non-profit organization...
The U.S. Department of Defense's Defense Health Agency awarded a $2,136,000.00 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) on May 1, 2025. The grant, provided under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research focused on "Reversibility and Therapeutic Targeting of Treatment-Emergent Neuroendocrine Prostate Cancer". This 3-year grant supports DFCI's work to develop innovative approaches for understanding,...